Cargando…

A Survey of Potentially Modifiable Patient-Level Factors Associated with Self-Report and Objectively Measured Adherence to Adjuvant Endocrine Therapies After Breast Cancer

PURPOSE: Despite the efficacy of adjuvant endocrine therapy (AET) in reducing breast cancer recurrence and mortality, suboptimal AET adherence is common and hence an important clinical issue among breast cancer survivors. Delineating potentially modifiable patient-level factors associated with AET a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toivonen, Kirsti I, Carlson, Linda E, Rash, Joshua A, Campbell, Tavis S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450192/ https://www.ncbi.nlm.nih.gov/pubmed/34552322 http://dx.doi.org/10.2147/PPA.S319087

Ejemplares similares

Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review
por: Toivonen, Kirsti I., et al.
Publicado: (2020)

Both “Vitamin L for Life” and “One Milligram of Satan”: A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer
por: Toivonen, Kirsti I., et al.
Publicado: (2021)

Protocol for a placebo-controlled, within-participants crossover trial evaluating the efficacy of intranasal oxytocin to improve pain and function among women with chronic pelvic musculoskeletal pain
por: Rash, Joshua A, et al.
Publicado: (2017)

Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Rosso, Roberta, et al.
Publicado: (2023)

Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
por: Lee, Joo Yun, et al.
Publicado: (2018)

Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence
por: Cahir, Caitriona, et al.
Publicado: (2023)

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
por: Makubate, B, et al.
Publicado: (2013)

Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy
por: Tan, Eng Hooi, et al.
Publicado: (2021)

Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
por: Lambert, Leah K., et al.
Publicado: (2021)

Oncologists’ perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer
por: Eraso, Yolanda
Publicado: (2019)

The Chemo-Gut Study: A Cross-Sectional Survey Exploring Physical, Mental, and Gastrointestinal Health Outcomes in Cancer Survivors
por: Deleemans, Julie M., et al.
Publicado: (2022)

Systematic adaptation of the adherence improving self‐management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach
por: Janssen, Anna M., et al.
Publicado: (2022)

Observer trait anxiety is associated with response bias to patient facial pain expression independent of pain catastrophizing
por: Rash, Joshua A, et al.
Publicado: (2015)

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
por: Wulaningsih, W., et al.
Publicado: (2018)

Open to Exploration? Association of Personality Factors With Complementary Therapy Use After Breast Cancer Treatment
por: Toivonen, Kirsti I., et al.
Publicado: (2018)

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence
por: Brett, Jo, et al.
Publicado: (2018)

Does patient health literacy impact adherence to adjuvant endocrine therapy in breast cancer patients?
por: Keim-Malpass, Jessica, et al.
Publicado: (2018)

Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore
por: Ali, Eskinder Eshetu, et al.
Publicado: (2017)

Web-Based Mindfulness Interventions for People With Physical Health Conditions: Systematic Review
por: Toivonen, Kirsti I, et al.
Publicado: (2017)

Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross‐sectional survey
por: Xu, Hui, et al.
Publicado: (2020)

Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2021)

Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life
por: Stewart, Sarah-Jane F., et al.
Publicado: (2023)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors
por: Camacho, Fabian T., et al.
Publicado: (2017)

Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review
por: Yussof, Izzati, et al.
Publicado: (2022)

The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy
por: Jiang, Haoran, et al.
Publicado: (2022)

Network Modeling of Complex Time-Dependent Changes in Patient Adherence to Adjuvant Endocrine Treatment in ER+ Breast Cancer
por: Shinn, Eileen H., et al.
Publicado: (2022)

Adherence to adjuvant endocrine therapy among White British and ethnic minority breast cancer survivors in the United Kingdom
por: McGuinness, Serena, et al.
Publicado: (2022)

A Meta-Analysis on Sex Differences in Resting-State Vagal Activity in Children and Adolescents
por: Koenig, Julian, et al.
Publicado: (2017)

Self-Reported Adherence to Oral Endocrine Therapy among Breast Cancer Patients in Jordan
por: Faqeer, Nour, et al.
Publicado: (2022)

Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group.
por: Uchino, J., et al.
Publicado: (1994)

Hobson’s choice or a horned dilemma: a grounded theory on adherence to adjuvant endocrine therapy verified with breast cancer survivors
por: AlOmeir, Othman, et al.
Publicado: (2022)

Codevelopment of a Text Messaging Intervention to Support Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: Mixed Methods Approach
por: Green, Sophie M C, et al.
Publicado: (2023)

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

Breast density predicts endocrine treatment outcome in the adjuvant setting
por: Cuzick, Jack
Publicado: (2012)

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
por: Lambert, Leah K., et al.
Publicado: (2018)

Adherence evaluation of endocrine treatment in breast cancer: methodological aspects
por: Oberguggenberger, Anne S, et al.
Publicado: (2012)

Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine Therapy
por: Hara, Fumikata, et al.
Publicado: (2010)

Improving Adherence to Adjuvant Endocrine Therapy in Sub-Saharan Africa: Challenges and Innovative Nurse-Driven Solutions
por: Fadelu, Temidayo A, et al.
Publicado: (2022)

Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression Analysis
por: Farias, Albert J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nftuh4bkigeopqhomniaqpoh4f